imipramine has been researched along with Hallervorden-Spatz Disease in 1 studies
Imipramine: The prototypical tricyclic antidepressant. It has been used in major depression, dysthymia, bipolar depression, attention-deficit disorders, agoraphobia, and panic disorders. It has less sedative effect than some other members of this therapeutic group.
imipramine : A dibenzoazepine that is 5H-dibenzo[b,f]azepine substituted by a 3-(dimethylamino)propyl group at the nitrogen atom.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Siegl, C | 1 |
| Hamminger, P | 1 |
| Jank, H | 1 |
| Ahting, U | 1 |
| Bader, B | 1 |
| Danek, A | 1 |
| Gregory, A | 1 |
| Hartig, M | 1 |
| Hayflick, S | 1 |
| Hermann, A | 1 |
| Prokisch, H | 1 |
| Sammler, EM | 1 |
| Yapici, Z | 1 |
| Prohaska, R | 1 |
| Salzer, U | 1 |
1 other study available for imipramine and Hallervorden-Spatz Disease
| Article | Year |
|---|---|
Alterations of red cell membrane properties in neuroacanthocytosis.
Topics: Acanthocytes; Adolescent; Adult; Basal Ganglia; Calcium; Case-Control Studies; Cations, Divalent; Ch | 2013 |